Related Experiment Video
Updated: Jun 25, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
MicroRNA Nano-Shuttles: Engineering Extracellular Vesicles as a Cutting-Edge Biotechnology Platform for Clinical Use
Nico G Menjivar1, Jaiden Oropallo2,3, Samuel Gebremedhn1,4
1Animal Reproduction and Biotechnology Laboratory (ARBL), Department of Biomedical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, 80523, USA.
Extracellular vesicles (EVs) are natural nanoscale drug delivery systems. Engineering EVs to carry microRNAs (miRNAs) offers a promising next-generation therapeutic platform for targeted treatments.
Area of Science:
- Nanomedicine
- Biotechnology
- Cell Biology
Background:
- Extracellular vesicles (EVs) are naturally secreted nanoparticles involved in intercellular communication.
- EVs possess intrinsic properties like low toxicity and high cargo capacity, making them ideal for drug delivery.
- MicroRNAs (miRNAs) within EVs can modulate recipient cell function, impacting biological and pathological processes.
Purpose of the Study:
- To review the therapeutic potential of extracellular vesicle-coupled microRNAs.
- To summarize EV biogenesis, contents, and function.
- To discuss current EV loading techniques and engineered EVs for clinical translation.
Main Methods:
- Review of existing literature on extracellular vesicles and microRNAs.
- Analysis of EV biogenesis, cargo, and intercellular communication roles.
- Evaluation of various techniques for loading EVs with therapeutic payloads, including miRNAs.
Main Results:
- EVs are versatile nanocarriers with significant potential in drug delivery.
- Engineered EVs can be utilized to deliver therapeutic miRNAs for targeted cellular modulation.
- Current research focuses on optimizing EV loading and engineering for clinical applications.
Conclusions:
- EV-based miRNA delivery represents a promising next-generation nanomedicine platform.
- Further research and development are crucial for the clinical translation of engineered EVs.
- EV-miRNA therapeutics hold potential for targeted treatments in various diseases.
More Related Videos
07:55Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
Published on: November 8, 2024
07:29Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023